EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Potassium Channels of the Airway Epithelium

Sandra Villanueva iD, Erwin Vera iD, Tábata Apablaza, Marcelo A Catalán iD, Carlos A Flores iD

Acta Physiologica · 2026

DOI: 10.1111/apha.70287 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Physiologica, 2026. Verfasst von Sandra Villanueva und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Estudios Científicos (CECs), Valdivia, Chile. Hauptthemen laut MEDLINE: Potassium Channels, Respiratory Mucosa, Mucociliary Clearance, Potassium. Die Arbeit nennt 140 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Agencia Nacional de Investigación y Desarrollo, Cystic Fibrosis Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Maintenance of potassium (K + ) homeostasis across cell membranes is essential for life. While systemic K + balance is primarily regulated by the kidneys and intestines, ion channels, pumps, and transporters govern K + movement across epithelial barriers at the cellular level. Despite the prevalence of diseases caused by disrupted K + homeostasis, the role of K + channels in the lungs has received comparatively little attention. The airway epithelium expresses a diverse array of K + channels that regulate key functions such as transepithelial ion transport, ciliary beating, and mucus secretion. These processes are fundamental components of mucociliary clearance (MCC), the primary innate defense mechanism of the lungs. Dysfunction of MCC is central to muco‐obstructive diseases, including cystic fibrosis (CF), chronic obstructive pulmonary disease (COPD), and asthma. While K + channels were once considered therapeutic targets for enhancing anion secretion in CF, initial interest waned. However, it has been reinvigorated by recent findings showing that drugs targeting CFTR can also modulate airway epithelial K + channels and facilitate MCC. In this review, we compile current evidence on targeting K + channels to treat muco‐obstructive diseases. We discuss therapeutic opportunities offered by K + channel modulators, highlight emerging functions of these channels in the airways, and outline priorities for future research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Potassium ChannelsRespiratory MucosaMucociliary ClearancePotassiumHumansAnimalsCystic Fibrosis Transmembrane Conductance Regulator

Stichwörter der Autor:innen

CFTRairwaysasthmamuco‐obstructionpotassium channels

Substanzen

Potassium ChannelsCystic Fibrosis Transmembrane Conductance RegulatorPotassium

Autor:innen und Institutionen

  • Centro de Estudios Científicos (CECs), Valdivia, Chile.
  • Facultad de Medicina, Universidad San Sebastián, Valdivia, Chile.
  • Estudiante Programa de Doctorado en Enfermedades Crónicas, Facultad de Medicina, Universidad San Sebastián, Valdivia, Chile.
  • Instituto de Fisiología, Universidad Austral de, Valdivia, Chile.
  • NanoAIR Center (ACT250073), Santiago, Chile.

ORCID-Profile: Sandra Villanueva, Erwin Vera, Marcelo A Catalán, Carlos A Flores

Förderung

  • Agencia Nacional de Investigación y Desarrollo
  • Cystic Fibrosis Trust

Zitieren

APA

Villanueva, S., Vera, E., Apablaza, T., Catalán, M. A., & Flores, C. A. (2026). Potassium Channels of the Airway Epithelium. Acta Physiologica. https://doi.org/10.1111/apha.70287

Vancouver

Villanueva S, Vera E, Apablaza T, Catalán MA, Flores CA. Potassium Channels of the Airway Epithelium. Acta Physiologica. 2026. doi:10.1111/apha.70287

BibTeX
@article{Villanueva2026,
  author = {Villanueva, Sandra and Vera, Erwin and Apablaza, Tábata and Catalán, Marcelo A and Flores, Carlos A},
  title = {Potassium Channels of the Airway Epithelium},
  journal = {Acta Physiologica},
  year = {2026},
  doi = {10.1111/apha.70287}
}
Kostenlos starten →